Erratum: Estrogen coordinates translation and transcription, revealing a role for NRSF in human breast cancer cellsö (Molecular Endocrinology (2010) 24, (1120-1135) doi: 10.1210/me.2009-0436);Estrogen coordinates translation and transcription, revealing a role for NRSF in human breast cancer cells

Molecular Endocrinology

Volumn 24, Issue 6, 2010, Pages 1120-1135

  Bronson, Michael W ^a   Hillenmeyer, Sara ^a   Park, Richard W ^a   Brodsky, Alexander S ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; MESSENGER RNA; NEURON RESTRICTIVE SILENCER FACTOR; RNA; STEROID HORMONE; TRANSCRIPTION FACTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL CYCLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENOME ANALYSIS; HORMONE ACTION; HUMAN; HUMAN CELL; POLYSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; UPREGULATION;

EID: 77954829983     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0436     Document Type: Erratum

References (76)

1. Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, Russell BA, Shah PK, Liu J, Khramtsov A, Tretiakova MS, Krausz TN, Olopade OI, Rimm DL, White KP 2008 Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol 4:188
2. Frasor J, Chang EC, Komm B, Lin CY, Vega VB, Liu ET, Miller LD, Smeds J, Bergh J, Katzenellenbogen BS 2006 Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res 66:7334-7340
3. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M 2006 Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38:1289-1297
4. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS 2004 Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER)α or ERβ in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 145:3473-3486
5. Mueller GC, Gorski J, Aizawa Y 1961 The role of protein synthesis in early estrogen action. Proc Natl Acad Sci USA 47:164-169
6. Hamilton TH 1963 Isotopic studies on estrogen-induced accelerations of ribonucleic acid and protein synthesis. Proc Natl Acad Sci USA 49:373-379
7. Pennequin P, Robins DM, Schimke RT 1978 Regulation of translation of ovalbumin messenger RNA by estrogens and progesterone in oviduct of withdrawn chicks. Eur J Biochem 90:51-58
8. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P 1986 Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134-139
9. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J 1986 Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150-1154
10. Braunstein S, Karpisheva K, Pola C, Goldberg J, Hochman T, Yee H, Cangiarella J, Arju R, Formenti SC, Schneider RJ 2007 A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell 28:501-512
11. Averous J, Proud CG 2006 When translation meets transformation: the mTOR story. Oncogene 25:6423-6435
12. McClusky DR, Chu Q, Yu H, Debenedetti A, Johnson LW, Meschonat C, Turnage R, McDonald JC, Abreo F, Li BD 2005 A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer. Ann Surg 242:584-590; discussion 590-592
13. Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, Perlman DM, Manivel JC, Sonenberg N, Yee D, Bitterman PB, Polunovsky VA2004 Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 5:553-563
14. Sonenberg N, Gingras AC 1998 The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol 10:268-275
15. Iorio MV, Casalini P, Tagliabue E, Ménard S, Croce CM 2008 MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer 44:2753-2759
16. - breast cancer. Genome Biol 10:R90
17. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM 2009 Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37:2584-2595
18. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y, Nakshatri H 2009 Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37:4850-4561
19. Mathews MB, Sonenberg N, Hershey JWB 2007 Origins and principles of translational control. In: Mathews MB, Sonenberg N, Hershey JWB, eds. Translational control in biology and medicine. Woodbury, NY: Cold Spring Harbor Laboratory Press; 1-40
20. Zimmer SG, DeBenedetti A, Graff JR 2000 Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis. Anticancer Res 20:1343-1351
21. Lazaris-Karatzas A, Montine KS, Sonenberg N 1990 Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345:544-547
22. Beeram M, Tan QT, Tekmal RR, Russell D, Middleton A, DeGraffenried LA 2007 Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling. Ann Oncol 18:1323-1328
23. Preiss T, Baron-Benhamou J, Ansorge W, Hentze MW 2003 Homodirectional changes in transcriptome composition and mRNA translation induced by rapamycin and heat shock. Nat Struct Biol 10:1039-1047
24. Dubik D, Shiu RP 1988 Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J Biol Chem 263:12705-12708
25. Blume JE, Shapiro DJ 1989 Ribosome loading, but not protein synthesis, is required for estrogen stabilization of Xenopus laevis vitellogenin mRNA. Nucleic Acids Res 17:9003-9014
26. Saceda M, Lindsey RK, Solomon H, Angeloni SV, Martin MB 1998 Estradiol regulates estrogen receptormRNAstability. J Steroid Biochem Mol Biol 66:113-120
27. Yang F, Schoenberg DR 2004 Endonuclease-mediated mRNA decay involves the selective targeting of PMR1 to polyribosome-bound substrate mRNA. Mol Cell 14:435-445
28. Dodson RE, Shapiro DJ 1997 Vigilin, a ubiquitous protein with 14 K homology domains, is the estrogen-inducible vitellogenin mRNA 3′-untranslated region-binding protein. J Biol Chem 272:12249-12252
29. Imai Y, Ishikawa E, Asada S, Sugimoto Y 2005 Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res 65:596-604
30. Mutoh K, Tsukahara S, Mitsuhashi J, Katayama K, Sugimoto Y 2006 Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells. Cancer Sci 97:1198-1204
31. Ordóñez-Morán P, Muñoz A 2009 Nuclear receptors: genomic and non-genomic effects converge. Cell Cycle 8:1675-1680
32. Kampa M, Pelekanou V, Castanas E 2008 Membrane-initiated steroid action in breast and prostate cancer. Steroids 73:953-960
33. Levin ER 2005 Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19:1951-1959
34. Lange CA, Gioeli D, Hammes SR, Marker PC 2007 Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu Rev Physiol 69:171-199
35. Yu J, Henske EP 2006 Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain. Cancer Res 66:9461-9466
36. Beilharz TH, Preiss T 2004 Translational profiling: the genome-wide measure of the nascent proteome. Brief Funct Genomic Proteomic 3:103-111
37. Arava Y, Boas FE, Brown PO, Herschlag D 2005 Dissecting eukaryotic translation and its control by ribosome density mapping. Nucleic Acids Res 33:2421-2432
38. Shenton D, Smirnova JB, Selley JN, Carroll K, Hubbard SJ, Pavitt GD, Ashe MP, Grant CM 2006 Global translational responses to oxidative stress impact upon multiple levels of protein synthesis. J Biol Chem 281:29011-29021
39. Rajasekhar VK, Viale A, Socci ND, Wiedmann M, Hu X, Holland EC 2003 Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol Cell 12:889-901
40. Bushell M, Stoneley M, Kong YW, Hamilton TL, Spriggs KA, Dobbyn HC, Qin X, Sarnow P, Willis AE 2006 Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. Mol Cell 23:401-412
41. Sampath P, Pritchard DK, Pabon L, Reinecke H, Schwartz SM, Morris DR, Murry CE 2008 A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. Cell Stem Cell 2:448-460
42. Koritzinsky M, Magagnin MG, van den Beucken T, Seigneuric R, Savelkouls K, Dostie J, Pyronnet S, Kaufman RJ, Weppler SA, Voncken JW, Lambin P, Koumenis C, Sonenberg N, Wouters BG 2006 Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J 25:1114-1125
43. Koritzinsky M, Seigneuric R, Magagnin MG, van den Beucken T, Lambin P, Wouters BG 2005 The hypoxic proteome is influenced by gene-specific changes in mRNA translation. Radiother Oncol 76:177-186
44. Thomas JD, Johannes GJ 2007 Identification of mRNAs that continue to associate with polysomes during hypoxia. RNA 13:1116-1131
45. Mamane Y, Petroulakis E, Martineau Y, Sato TA, Larsson O, Rajasekhar VK, Sonenberg N 2007 Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS ONE 2:e242
46. Law GL, Bickel KS, MacKay VL, Morris DR 2005 The undertranslated transcriptome reveals widespread translational silencing by alternative 5′ transcript leaders. Genome Biol 6:R111
47. De Benedetti A, Graff JR 2004 eIF-4E expression and its role in malignancies and metastases. Oncogene 23:3189-3199
48. Melamed D, Pnueli L, Arava Y 2008 Yeast translational response to high salinity: global analysis reveals regulation at multiple levels. RNA 14:1337-1351
49. Lackner DH, Beilharz TH, Marguerat S, Mata J, Watt S, Schubert F, Preiss T, Bähler J 2007 A network of multiple regulatory layers shapes gene expression in fission yeast. Mol Cell 26:145-155
50. Coulson JM 2005 Transcriptional regulation: cancer, neurons and the REST. Curr Biol 15:R665-R668
51. Majumder S 2006 REST in good times and bad: roles in tumor suppressor and oncogenic activities. Cell Cycle 5:1929-1935
52. Lupien M, Eeckhoute J, Meyer CA, Krum SA, Rhodes DR, Liu XS, Brown M 2009 Coactivator function defines the active estrogen receptor α cistrome. Mol Cell Biol 29:3413-3423
53. Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS 2004 Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res 64:1522-1533
54. Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, Xie M, Chiu KP, Lipovich L, Barnett DH, Stossi F, Yeo A, George J, Kuznetsov VA, Lee YK, Charn TH, Palanisamy N, Miller LD, Cheung E, Katzenellenbogen BS, Ruan Y, Bourque G, Wei CL, Liu ET 2007 Whole-genome cartography of estrogen receptor α binding sites. PLoS Genet 3:e87
55. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550
56. Mootha VK, Handschin C, Arlow D, Xie X, St Pierre J, Sihag S, Yang W, Altshuler D, Puigserver P, Patterson N, Willy PJ, Schulman IG, Heyman RA, Lander ES, Spiegelman BM 2004 Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci USA 101:6570-6575
57. Wei G, Twomey D, Lamb J, Schlis K, Agarwal J, Stam RW, Opferman JT, Sallan SE, den Boer ML, Pieters R, Golub TR, Armstrong SA 2006 Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 10:331-342
58. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M 2005 Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33-43
59. Trask HW, Cowper-Sal-lari R, Sartor MA, Gui J, Heath CV, Renuka J, Higgins AJ, Andrews P, Korc M, Moore JH, Tomlinson CR 2009 Microarray analysis of cytoplasmic versus whole cell RNA reveals a considerable number of missed and false positive mRNAs. RNA 15:1917-1928
60. Stender JD, Frasor J, Komm B, Chang KC, Kraus WL, Katzenellenbogen BS 2007 Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Mol Endocrinol 21:2112-2123
61. Matthews J, Gustafsson JA 2006 Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl Recept Signal 4:e016
62. Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, Feng B, Zhao JJ, Roberts TM, Mandel G, Hannon GJ, Depinho RA, Chin L, Elledge SJ 2005 A genetic screen for candidate tumor suppressors identifies REST. Cell 121:837-848
63. Reddy BY, Greco SJ, Patel PS, Trzaska KA, Rameshwar P 2009 RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells. Proc Natl Acad Sci USA 106:4408-4413
64. Weissman AM 2008 How much REST is enough? Cancer Cell 13:381-383
65. Abramovitz L, Shapira T, Ben-Dror I, Dror V, Granot L, Rousso T, Landoy E, Blau L, Thiel G, Vardimon L 2008 Dual role of NRSF/REST in activation and repression of the glucocorticoid response. J Biol Chem 283:110-119
66. Keeton EK, Brown M 2005 Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-α and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. Mol Endocrinol 19:1543-1554
67. Lagadec C, Adriaenssens E, Toillon RA, Chopin V, Romon R, Van Coppenolle F, Hondermarck H, Le Bourhis X 2008 Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells. Oncogene 27:1472-1477
68. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM 2007 Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9:166-180
69. de Sousa Abreu R, Penalva LO, Marcotte EM, Vogel C 2009 Global signatures of protein and mRNA expression levels. Mol Biosyst 5:1512-1526
70. Beissbarth T, Speed TP 2004 GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20:1464-1465
71. Dai MS, Lu H 2008 Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J Cell Biochem 105:670-677
72. Komili S, Silver PA 2008 Coupling and coordination in gene expression processes: a systems biology view. Nat Rev Genet 9:38-48
73. Moore MJ, Proudfoot NJ 2009 Pre-mRNA processing reaches back to transcription and ahead to translation. Cell 136:688-700
74. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y 1987 Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res 47:4355-4360
75. Karolchik D, Kuhn RM, Baertsch R, Barber GP, Clawson H, Diekhans M, Giardine B, Harte RA, Hinrichs AS, Hsu F, Kober KM, Miller W, Pedersen JS, Pohl A, Raney BJ, Rhead B, Rosenbloom KR, Smith KE, Stanke M, Thakkapallayil A, Trumbower H, Wang T, Zweig AS, Haussler D, Kent WJ 2008 The UCSC Genome Browser Database: 2008 update. Nucleic Acids Res 36(Database issue):D773-D779
76. McKee AE, Neretti N, Carvalho LE, Meyer CA, Fox EA, Brodsky AS, Silver PA 2007 Exon expression profiling reveals stimulusmediated exon use in neural cells. Genome Biol 8:R159